Transcatheter Pulmonary Valve Implantation in Carcinoid Heart Disease - Archive ouverte HAL Access content directly
Journal Articles Cardiovascular Revascularization Medicine Year : 2022

Transcatheter Pulmonary Valve Implantation in Carcinoid Heart Disease

(1) , (2, 1) , (1) , (1) , (3) , (1, 4) , (5, 1) , (3) , (5, 1)
1
2
3
4
5

Abstract

Carcinoid heart disease is a rare condition affecting mostly tricuspid and pulmonary valves causing right-sided heart failure. Surgical valve replacement is the mainstay of treatment when patients become symptomatic and/or in the presence of right heart remodeling. We present a case of severe pulmonary valve regurgitation secondary to carcinoid heart disease occurring 4 years after a surgical tricuspid replacement, successfully treated with direct transcatheter pulmonary valve implantation without pre-stenting.
Not file

Dates and versions

inserm-03831063 , version 1 (26-10-2022)

Identifiers

Cite

M. Flagiello, M. Pozzi, L. Francois, A. Al Harthy, J. Forestier, et al.. Transcatheter Pulmonary Valve Implantation in Carcinoid Heart Disease. Cardiovascular Revascularization Medicine, 2022, 40s, pp.130-134. ⟨10.1016/j.carrev.2021.12.027⟩. ⟨inserm-03831063⟩
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More